the Efficacy and Safety of HRS9531 Injection in Subjects With Type 2 Diabetes， Inadequately Controlled With Diet and Exercise Alone

Summary

The primary objective of this study is to evaluate the effectiveness of HRS9531 compared to placebo in controlling blood glucose levels after 36 weeks of treatment

Timeline

Start

2024-11-08

Primary completion

2026-01-21

Completion

2026-06-12

Outcome

Met primary endpoint

release “HRS9531-302）取得积极顶线结果，主要终点及所有关键次要终点均达到优效” hengrui.com ↗

Drugs

Indications